Matthew Winton Inozyme Pharma, Inc. (INZY) insider trading activity
Matthew Winton is COO of Inozyme Pharma, Inc.. Currently has a direct ownership of 4,898 shares of INZY, which is worth approximately $14,645. The most recent transaction as insider was on Sep 30, 2024, when has been sold 1,710 shares (Common Stock) at a price of $4.45 per share, resulting in proceeds of $7,609. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
4.9K
53.64%
3M change
n/a
12M change
Total Value Held
$14,645
Matthew Winton Transaction History
MW
Matthew Winton
COO
Boston, MA